CADTH Reimbursement Review - Cenobamate (Xcopri) - Sponsor: Paladin Labs Inc. Therapeutic area: Epilepsy, partial onset seizures

Canadian Agency for Drugs and Technologies in Health

Share artifact

Or copy link:

Register Login

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Add to list

You have no lists yet

Manage lists

Citation

Health, C., 2023. CADTH Reimbursement Review - Cenobamate (Xcopri) - Sponsor: Paladin Labs Inc. Therapeutic area: Epilepsy, partial onset seizures, Canadian Agency for Drugs and Technologies in Health. Canada. Retrieved from https://canadacommons.ca/artifacts/11208851/cadth-reimbursement-review-cenobamate-xcopri-sponsor/12087866/ on 27 Apr 2024. CID: 20.500.12592/893242b.

Download citation (RIS)

Full-page Screenshot

Screenshot of https://coherent-commons.s3.amazonaws.com/artifacts/file/file/61d09d7b-9e6a-4730-853f-321a129476c3.pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA23B6R4NTCRHS5NZ3%2F20240427%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20240427T190951Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=2a71af72e87535330a0a1bfac576fdfd45f5caae4aa710a83f031d5d3ff5e1d4

CADTH Reimbursement Review - Cenobamate (Xcopri) - Sponsor: Paladin Labs Inc. Therapeutic area: Epilepsy, partial onset seizures

Authors